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46 Functional properties of CFTR in human monocytes measured by
patch clamp technique
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CFTR is a protein widely distributed in a variety of cell types. We have recently
shown that human monocytes express CFTR and we developed a single-cell
ﬂuorescence imaging assay to evaluate CFTR activity in isolated cells. In the present
work, we characterized the electrophysiological properties of CFTR, by patch clamp
technique, in human monocytes from healthy and CF subjects and related it to single
cell ﬂuorescence imaging. cAMP-dependent chloride currents were detected only
in cells from healthy subjects with a concordance between the two methods. These
data further support previous observations from our group showing that monocytes
could be useful for diagnosing CF and possibly to assess the effects of drugs active
on the basic defect.
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Secretory diarrhoea continues to be an enormous health problem worldwide.
Pharmacological block of the cystic ﬁbrosis transmembrane conductance regulator
(CFTR) chloride channel is regarded as a potential therapeutic target for secretory
diarrhoea. The main objective of this study was to determine the action of the plant
derived compound, reserpine, on the CFTR chloride channel.
The effect of reserpine on the CFTR chloride current was investigated using the
short circuit current (Isc) technique on monolayers of Caco-2 cells grown on perme-
able supports. Monolayers had a transepithelial resistance (RT) of 467±40W/cm2
and an initial Isc of 4.5±1.2mA/cm2 (n = 22).
Initial experiments on intact Caco-2 monolayers suggested that a 15 min, api-
cal preincubation with 50mM reserpine resulted in an inhibition of the 10mM
forskolin-stimulated Isc (n = 3). All further experiments were carried out in nystatin-
permeabilised Caco-2 monolayers. Basolateral addition of 10mM Forskolin resulted
in an increase in Isc of 68±12.6mA/cm2 (n = 3) which was completely inhibited by
apical addition of 50mM GlyH101. Forskolin-stimulated (10mM) Isc was inhibited
by apical addition of reserpine (10−50mM) in a concentration dependent manner
(n = 1). Further investigation of this result demonstrated that the forskolin-stimulated
Isc was inhibited by 71% (n = 3) after a 15min, apical preincubation with reserpine
(50mM). A 15min, basolateral preincubation with reserpine (50mM) also resulted
in a 43% (n = 3) inhibition of the forskolin-stimulated Isc.
The data suggest that reserpine potentially targets the CFTR chloride channel and
may be useful for further development as an antidiarrhoeal agent.
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Measurements of CFTR function in rectal biopsies ex vivo have been used for the
diagnosis and prognosis of Cystic Fibrosis (CF) disease. Here, we aimed to evaluate
this procedure regarding:
1. viability of the rectal specimens obtained by biopsy forceps for ex vivo bioelec-
trical/biochemical analyses;
2. overall assessment (comfort, invasiveness, pain, sedation requirement) of the
rectal forceps biopsy from the patients perspective to assess its feasibility as an
outcome measure in clinical trials.
Methods: We compared three bowel preparation solutions (NaCl 0.9%, glycerol
12%, mannitol), and two biopsy forceps (standard and jumbo) in 580 rectal
specimens from 132 individuals (CF and non-CF). 75 CF individuals who underwent
the sigmoidoscopy were assessed by telephone surveys.
Results: Integrity and friability of the tissue specimens correlate with their transep-
ithelial resistance (r = −0.438 and −0.305, respectively), both are inﬂuenced by
the bowel preparation solution and biopsy forceps used, being NaCl and jumbo
forceps the most compatible methods with the electrophysiological analysis. The
great majority of the individuals (76%) did not report major discomfort due to
the short procedure time (max 15min) and considered it relatively painless (79%).
Importantly, most (88%) accept repeating it at least for one more time.
Conclusions: Obtaining rectal biopsies with a ﬂexible endoscope and jumbo forceps
after bowel preparation with NaCl solution is a safe procedure for both children and
adults and yelds viable specimens for CFTR bioelectrical/biochemical analyses. The
procedure is well tolerated by patients, demonstrating its feasibility as an outcome
measure in clinical trials.
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Objectives: In 2004 Best and Quinton [1] established the salivary secretion assay
in mice for the in vivo characterization of new drugs against Cystic Fibrosis (CF).
However, limited in vivo data are available and the predictive value of this assay for
treatment effects in CF patients is not fully established. Therefore, we systematically
investigated the salivary secretion rates and established salivary chloride content
measurments in CF mice, in CFTR knockout mice (CFTRtm1Unc) as well as in the
F508del CFTR mice of different origin (CFTRtm1Kth and CFTRtm1Eur).
Methods: The b-adrenergic salivary secretion response in the presence of Atropine
was quantiﬁed and found signiﬁcantly reduced compared to WT mice. Salivary
secretion rates of CF CFTRtm1Kth and CF CFTRtm1Eur mice were reduced 13-
fold and 10-fold respectively when compared to WT mice. Salivary rates of CF
CFTRtm1Unc mice were 30-fold reduced. Saliva was collected after Pilocarpine
stimulation and chloride levels were quantiﬁed using a colometric Chloride deter-
mination assay. Saliva chloride was signiﬁcantly elevated in all CF mouse models.
The chloride concentrations were 2.1-fold higher in CF CFTRtm1Unc, 1.8-fold in
CF CFTRtm1Kth and 3.3-fold in CF CFTRtm1Eur when compared to WT mice.
Conclusion: Salivary secretion rates and salivary chloride content in CF-mice
reﬂect sweat secretion and sweat chloride content in CF patients. Determination of
salivary secretion rates, extended by quantiﬁcation of salivary chloride content in
different CF-mice renders the salivary secretion assay a powerful tool for validation
of new CF-treatments.
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